- Solid oral nutraceutical excipients, which support the formulation, stability, and effectiveness of dietary supplements, are becoming increasingly important for tablets, capsules, and powders across preventive and therapeutic nutrition in the EMEA region
- The rising demand is largely driven by growing consumer interest in health and wellness, an aging population, and increasing use of supplements for immune support, digestive health, and chronic condition management
- Europe dominated the EMEA solid oral nutraceutical excipient market with the largest revenue share of 63.2% in 2024, supported by advanced manufacturing capabilities, stringent quality regulations, and high consumer awareness in countries like Germany, France, and the U.K.
- The Middle East and Africa are projected to be the fastest growing region in the EMEA solid oral nutraceutical excipient market during the forecast period due to increasing healthcare investments, growing middle-class populations, and heightened interest in nutritional products
- Binder segment dominated the solid oral nutraceutical excipient market with a market share of 39.1% in 2024, owing to its critical role in maintaining tablet cohesion, stability, and uniformity in solid dosage forms
